Ghost Tree Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-225,000
| Closed | -$13.8M | – | 54 |
|
|
2017
Q3 | $13.8M | Buy |
225,000
+75,000
| +50% | +$4.6M | 2.93% | 5 |
|
|
2017
Q2 | $6.9M | Sell |
150,000
-150,000
| -50% | -$6.9M | 1.43% | 20 |
|
|
2017
Q1 | $13M | Buy |
+300,000
| New | +$13M | 2.42% | 3 |
|
|
2016
Q3 | – | Sell |
-125,000
| Closed | -$5.68M | – | 77 |
|
|
2016
Q2 | $5.68M | Buy |
+125,000
| New | +$5.68M | 1.64% | 16 |
|
|
2015
Q4 | – | Sell |
-55,000
| Closed | -$2.19M | – | 63 |
|
|
2015
Q3 | $2.19M | Sell |
55,000
-67,500
| -55% | -$2.69M | 0.98% | 36 |
|
|
2015
Q2 | $5.85M | Buy |
+122,500
| New | +$5.85M | 1.9% | 20 |
|
|
2014
Q4 | – | Sell |
-100,000
| Closed | -$1.57M | – | 72 |
|
|
2014
Q3 | $1.57M | Buy |
+100,000
| New | +$1.57M | 0.85% | 40 |
|